Use of Yeast-Secreted In vivo Biotinylated Recombinant Antibodies (Biobodies) in Bead-Based ELISA
Data up to Jan 2025
Total Citations Per Year
Abstract
References (30)
Comparing the Areas under Two or More Correlated Receiver Operating Characteristic Curves: A Nonparametric Approach
1988 • 19,163 citations
An Introduction to Statistical Methods and Data Analysis
1994 • 5,244 citations
A Radioimmunoassay Using a Monoclonal Antibody to Monitor the Course of Epithelial Ovarian Cancer
1983 • 2,102 citations
The area above the ordinal dominance graph and the area below the receiver operating characteristic graph
1975 • 1,423 citations
Multiplexed particle-based flow cytometric assays
2000 • 902 citations
Molecular cloning of mesothelin, a differentiation antigen present on mesothelium, mesotheliomas, and ovarian cancers.
1996 • 692 citations
The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma.
2003 • 690 citations
Human Epididymis Protein 4 (HE4) Is a Secreted Glycoprotein that Is Overexpressed by Serous and Endometrioid Ovarian Carcinomas
2005 • 557 citations
Mesothelin-family proteins and diagnosis of mesothelioma
2003 • 533 citations
Flow-cytometric isolation of human antibodies from a nonimmune Saccharomyces cerevisiae surface display library
2003 • 496 citations
New tumor markers: CA125 and beyond
2005 • 457 citations
Comparative hybridization of an array of 21 500 ovarian cDNAs for the discovery of genes overexpressed in ovarian carcinomas
1999 • 398 citations
Potential markers that complement expression of CA125 in epithelial ovarian cancer
2005 • 357 citations
Lessons from BRCA: The Tubal Fimbria Emerges as an Origin for Pelvic Serous Cancer
2007 • 343 citations
Soluble member(s) of the mesothelin/megakaryocyte potentiating factor family are detectable in sera from patients with ovarian carcinoma
1999 • 322 citations
Detection and Quantitation of Serum Mesothelin, a Tumor Marker for Patients with Mesothelioma and Ovarian Cancer
2006 • 280 citations
Combining CA 125 and SMR serum markers for diagnosis and early detection of ovarian carcinoma
2004 • 188 citations
Bead-Based ELISA for Validation of Ovarian Cancer Early Detection Markers
2006 • 142 citations
Multiplexed Analysis of Human Cytokines by Use of the FlowMetrix System
1998 • 142 citations
Mesothelin Variant 1 Is Released from Tumor Cells as a Diagnostic Marker
2006 • 108 citations
Linear Regression and Correlation
2009 • 106 citations
Ovarian cancer screening
2003 • 83 citations
Expression of candidate tumor markers in ovarian carcinoma and benign ovary: Evidence for a link between epithelial phenotype and neoplasia
2004 • 70 citations
Development of a CA125-mesothelin cell adhesion assay as a screening tool for biologics discovery
2006 • 66 citations
Development and in vitro validation of anti-mesothelin biobodies that prevent CA125/Mesothelin-dependent cell attachment
2007 • 62 citations
Method for generation of in vivo biotinylated recombinant antibodies by yeast mating
2006 • 47 citations
Changes in cancer worry associated with participation in ovarian cancer screening
2007 • 47 citations
GPI-specific phospholipase D mRNA expression in tumor cells of different malignancy.
2002 • 19 citations
Compliance of Average- and Intermediate-Risk Women to Semiannual Ovarian Cancer Screening
2004 • 19 citations
Comparing adaptive and non-adaptive algorithms for cancer early detection with novel biomarkers
2006 • 7 citations
Cited By (0)
No citing papers found in database